ライフサイエンス出版株式会社

FacebookTwitterInstagram
menu

Japanese Pharmacology & Therapeutics(JPT)

Vol. 50 No. 2 2022

■ ORIGINAL ARTICLES

Coronavirus OC43 infection‒inhibitory effect of Kuromoji(Lindera umbellata Thunb.)hot water extract

T. Kawahara, et al.

Jpn Pharmacol Ther 2022 50(2)195-201


Post hoc stratified analysis of uric acid‒lowering effects of dotinurad based on pretreatment serum uric acid levels

T. Takahashi, et al.

Jpn Pharmacol Ther 2022 50(2)203-12


Safety of long—term administration of a systemic—acting diclofenac sodium patch(HP—3150)in Japanese patients with low back pain

T. Taguchi, et al.

Jpn Pharmacol Ther 2022 50(2)213-27


Effects of Lactobacillus kefiri GKL2 on bowel movement and on intestinal flora in healthy subjects
– A randomized, placebo controlled, double‒blind, paralleled study –

T. Nakano, et al.

Jpn Pharmacol Ther 2022 50(2)229-35


Effects of kaki—tannin on reducing serum LDL cholesterol levels in volunteers with borderline and mild hyper—LDL cholestrolemia
– A randomized, double—blind, placebo—controlled, parallel—group comparison trial –

T. Suzuki, et al.

Jpn Pharmacol Ther 2022 50(2)237-46


Effects of oral ingestion of hotrienol on autonomic nervous system activity and central nervous function
– Randomized, placebo‒controlled, double‒blind, parallel‒group study –

M. Suzuki, et al.

Jpn Pharmacol Ther 2022 50(2)247-56


Effects of Shiikuwashas(Citrus depressa)‒derived nobiletin and tangeretin foods on eye and nasal allergic reactions
– A randomized, placebo‒controlled, double‒blind parallel‒group study –

Y. Ogido, et al.

Jpn Pharmacol Ther 2022 50(2)257-65


Sleep improvement effect of kwanso-deriverd hypnocallis® -I
– Sleep improvement effect with the OSA sleep questionnaire –

A. Sawabe, et al.

Jpn Pharmacol Ther 2022 50(2)267-73